# The Effect of Ruboxistaurin on Small Fiber Function

> **NCT00190970** · PHASE2 · COMPLETED · sponsor: **Chromaderm, Inc.** · enrollment: 52 (—)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** Ruboxistaurin

## Key facts

- **NCT ID:** NCT00190970
- **Lead sponsor:** Chromaderm, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 52 (—)
- **Last updated:** 2016-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190970, "The Effect of Ruboxistaurin on Small Fiber Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00190970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*